Annual Report
Data Management: Alternative Models for Source Data Verification
Adaptive Designs Working Group September 27, 2006 Washington, D.C. FDA/Industry Statistics Workshop Adaptive Clinical Trials Short Course Presenters: Michael.
Competitve Intelligence
N o r t h A m e r i c a E u r o p e A s i a / P a c i f i c L a t i n A m e r i c a A f r i c a 1 Adaptive Trial Designs and Considerations October 19,
Adaptive Designs Working Group October 27, 2006 ASA/Philadelphia FDA/Industry Statistics Workshop Adaptive Designs Sample size re-estimation: A review.
Adaptive Designs Working Group Adaptive Designs Logistic, Operational and Regulatory Issues Judith Quinlan Biopharm Statistics Leader Drug Discovery Sciences.
Merck An Overview of Issues Surrounding Multi-Regional Clinical Trials Bruce Binkowitz Merck & Co. [email protected] May 28, 2009.
Clinical Trials for Quality of Life Endpoints in Oncology Oncology Education Session Rochester, November 1, 2005 Oncology Education Session Rochester,
1 © Roche 2012. ANZ Clinical trials – what is the future? 21 st March, 2013 Dr Dan Thurley MD Medical Director Australia & Asia Pacific, Roche picture.
Christopher C. Gallen, M.D., Ph.D. Vice President, Wyeth Research Strategic Challenges in Neuroprotective Drug Development March 15, 2003 Washington, D.C.
Iranian Pharmacovigilance Center Research & Development Office Undersecretary for Food & Drug Ministry of Health & Medical Education.
